NCT00093353 2026-04-14
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
New Approaches to Neuroblastoma Therapy Consortium
Dana-Farber Cancer Institute
Shanghai Juncell Therapeutics
Shanghai Juncell Therapeutics
Istanbul University - Cerrahpasa
Faculdade de Farmácia